La Manna, S.; Lopez-Sanz, L.; Bernal, S.; Jimenez-Castilla, L.; Prieto, I.; Morelli, G.; Gomez-Guerrero, C.; Marasco, D.
Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis. Antioxidants 2020, 9, 754.
https://doi.org/10.3390/antiox9080754
AMA Style
La Manna S, Lopez-Sanz L, Bernal S, Jimenez-Castilla L, Prieto I, Morelli G, Gomez-Guerrero C, Marasco D.
Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis. Antioxidants. 2020; 9(8):754.
https://doi.org/10.3390/antiox9080754
Chicago/Turabian Style
La Manna, Sara, Laura Lopez-Sanz, Susana Bernal, Luna Jimenez-Castilla, Ignacio Prieto, Giancarlo Morelli, Carmen Gomez-Guerrero, and Daniela Marasco.
2020. "Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis" Antioxidants 9, no. 8: 754.
https://doi.org/10.3390/antiox9080754
APA Style
La Manna, S., Lopez-Sanz, L., Bernal, S., Jimenez-Castilla, L., Prieto, I., Morelli, G., Gomez-Guerrero, C., & Marasco, D.
(2020). Antioxidant Effects of PS5, a Peptidomimetic of Suppressor of Cytokine Signaling 1, in Experimental Atherosclerosis. Antioxidants, 9(8), 754.
https://doi.org/10.3390/antiox9080754